RS

Richard E. Showalter

AP Agouron Pharmaceuticals: 5 patents #50 of 327Top 20%
PG Polaris Group: 3 patents #2 of 18Top 15%
📍 El Cajon, CA: #40 of 572 inventorsTop 7%
🗺 California: #66,801 of 386,348 inventorsTop 20%
Overall (All Time): #538,433 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12344645 Protein conjugates Robert Almassy, Elena Brin, James A. Thomson 2025-07-01
11235037 Arginine deiminase with reduced cross-reactivity toward ADI - PEG 20 antibodies for cancer treatment Robert Almassy, James A. Thomson, Wes Sisson, Wei-Jong Shia, Li-Chang Chen +1 more 2022-02-01
10463721 Engineered chimeric pegylated ADI and methods of use Bor-Wen Wu, Robert Almassy, Wei He, Jiaojuan He, Yunyun Guo +1 more 2019-11-05
9789170 Arginine deiminase with reduced cross-reactivity toward ADI-PEG 20 antibodies for cancer treatment Robert Almassy, James A. Thomson, Wes Sisson, Wei-Jong Shia, Li-Chang Chen +1 more 2017-10-17
6849721 Modifications of the VEGF receptor-2 protein and methods of use Michele Ann McTigue, Chris Pinko, Camran V. Parast, Michael R. Gehring, Chen-Chen Kan +5 more 2005-02-01
6794146 Modifications of the VEGF receptor-2 protein and methods of use Michele Ann McTigue, Chris Pinko, Camran V. Parast, Michael R. Gehring, Chen-Chen Kan +5 more 2004-09-21
6784285 Modifications of the VEGF Receptor-2 Protein and methods of use Michele Ann McTigue, Chris Pinko, Camran V. Parast, Michael R. Gehring, Chen-Chen Kan +5 more 2004-08-31
6753416 Modifications of the VEGF receptor-2 protein and methods of use Michele Ann McTigue, Chris Pinko, Camran V. Parast, Michael R. Gehring, Chen-Chen Kan +5 more 2004-06-22
6316603 Modifications of the VEGF receptor-2 protein and methods of use Michele Ann McTigue, Chris Pinko, Camran V. Parast, Michael R. Gehring, Chen-Chen Kan +5 more 2001-11-13